PRR22
gene geneOn this page
Also known as MGC24975
Summary
PRR22 (proline rich 22, HGNC:28354) is a protein-coding gene on chromosome 19p13.3, encoding Proline-rich protein 22 (Q8IZ63).
At a glance
- Clinical variants (ClinVar): 101 total
- MANE Select transcript:
NM_001134316
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28354 |
| Approved symbol | PRR22 |
| Name | proline rich 22 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC24975 |
| Ensembl gene | ENSG00000212123 |
| Ensembl biotype | protein_coding |
| Entrez | 163154 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000390672, ENST00000419421
RefSeq mRNA: 1 — MANE Select: NM_001134316
NM_001134316
CCDS: CCDS45933
Canonical transcript exons
ENST00000419421 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001622902 | 5784377 | 5784439 |
| ENSE00001742088 | 5782960 | 5784053 |
| ENSE00001774156 | 5784531 | 5784746 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 91.99.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1188 / max 109.6137, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178561 | 0.1188 | 3 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 91.99 | gold quality |
| left testis | UBERON:0004533 | 91.77 | gold quality |
| testis | UBERON:0000473 | 87.87 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.47 | gold quality |
| right uterine tube | UBERON:0001302 | 83.09 | gold quality |
| right lobe of liver | UBERON:0001114 | 79.00 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 74.80 | gold quality |
| metanephros cortex | UBERON:0010533 | 74.56 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.18 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 73.52 | gold quality |
| skin of leg | UBERON:0001511 | 73.50 | gold quality |
| skin of abdomen | UBERON:0001416 | 73.12 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 73.05 | gold quality |
| body of pancreas | UBERON:0001150 | 72.68 | gold quality |
| minor salivary gland | UBERON:0001830 | 72.47 | gold quality |
| granulocyte | CL:0000094 | 72.25 | gold quality |
| body of stomach | UBERON:0001161 | 71.92 | gold quality |
| left uterine tube | UBERON:0001303 | 71.81 | gold quality |
| transverse colon | UBERON:0001157 | 71.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.65 | gold quality |
| spleen | UBERON:0002106 | 71.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 71.45 | gold quality |
| thyroid gland | UBERON:0002046 | 71.21 | gold quality |
| esophagus mucosa | UBERON:0002469 | 70.86 | gold quality |
| apex of heart | UBERON:0002098 | 69.48 | gold quality |
| zone of skin | UBERON:0000014 | 69.32 | gold quality |
| small intestine | UBERON:0002108 | 69.06 | gold quality |
| right frontal lobe | UBERON:0002810 | 68.45 | gold quality |
| right ovary | UBERON:0002118 | 68.43 | gold quality |
| mouth mucosa | UBERON:0003729 | 68.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.57 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prr22 | ENSMUSG00000090273 |
| rattus_norvegicus | Prr22 | ENSRNOG00000047295 |
Protein
Protein identifiers
Proline-rich protein 22 — Q8IZ63 (reviewed: Q8IZ63)
All UniProt accessions (2): K7EJN8, Q8IZ63
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (1): NP_001127788* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031535 | PRR22 | Family |
Pfam: PF15776
UniProt features (8 total): region of interest 3, compositionally biased region 2, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IZ63-F1 | 52.46 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 31 (showing top):
chr19p13, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, MARTENS_TRETINOIN_RESPONSE_DN, ZNF436_TARGET_GENES, ZNF92_TARGET_GENES, HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN, GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP, PEREZ_TP53_TARGETS, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN, GSE2706_2H_VS_8H_R848_STIM_DC_DN, TGTTTGY_HNF3_Q6, GSE27786_BCELL_VS_MONO_MAC_DN, GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN, GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP, GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
202 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRR22 | CATSPERD | Q86XM0 | 580 |
| PRR22 | TMEM247 | A6NEH6 | 553 |
| PRR22 | ZNF514 | Q96K75 | 479 |
| PRR22 | SLC25A41 | Q8N5S1 | 478 |
| PRR22 | DUS3L | Q96G46 | 456 |
| PRR22 | YJU2B | P13994 | 447 |
| PRR22 | SPCS1 | Q9Y6A9 | 403 |
| PRR22 | A0A0A6YYG8 | A0A0A6YYG8 | 397 |
| PRR22 | GRPEL2 | Q8TAA5 | 393 |
| PRR22 | ORMDL2 | Q53FV1 | 392 |
| PRR22 | RFX2 | P48378 | 392 |
| PRR22 | A0A0B4J2G0 | A0A0B4J2G0 | 375 |
| PRR22 | GTF2IRD2B | Q6EKJ0 | 373 |
| PRR22 | N4BP2L2 | Q92802 | 372 |
| PRR22 | MRPL51 | Q4U2R6 | 371 |
| PRR22 | GTF2IRD2 | Q86UP8 | 371 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT8 | PRR22 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PRR22 | DDI1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRR22 | nrdB | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRR22 | ubiF | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRR22 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (32): PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid), PRR22 (Two-hybrid)
ESM2 similar proteins: A2A9A2, A2D4R4, A2D649, A2T6H5, A2T7H5, D3YWE6, E9PYL2, O15054, O15353, O15417, O35126, O43365, P02831, P18111, P31260, P31310, P47902, P50548, P54259, P70459, P78411, P78413, P78414, P78415, P81066, P81067, P81068, Q08DG7, Q10571, Q2HJ78, Q2VWA4, Q3UHR0, Q5IS70, Q5NCY0, Q5TGY3, Q5U5X8, Q61572, Q64HY5, Q6PAL7, Q6PGH4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
101 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 92 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
475 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:5784529:AC:A | donor_gain | 0.9500 |
| 19:5784530:CC:C | donor_gain | 0.9500 |
| 19:5784586:AGCCC:A | donor_gain | 0.9300 |
| 19:5784524:ATCGT:A | donor_loss | 0.9200 |
| 19:5784525:TCGTA:T | donor_loss | 0.9200 |
| 19:5784526:CGTAC:C | donor_loss | 0.9200 |
| 19:5784528:TA:T | donor_loss | 0.9200 |
| 19:5784529:ACCCA:A | donor_loss | 0.9200 |
| 19:5784530:C:A | donor_loss | 0.9200 |
| 19:5784536:G:C | donor_gain | 0.9200 |
| 19:5784529:A:AC | donor_gain | 0.9000 |
| 19:5784530:C:CC | donor_gain | 0.9000 |
| 19:5784052:ACCTG:A | acceptor_loss | 0.8700 |
| 19:5784054:CTGTG:C | acceptor_loss | 0.8700 |
| 19:5784055:T:C | acceptor_loss | 0.8700 |
| 19:5784056:G:C | acceptor_loss | 0.8700 |
| 19:5784523:GATC:G | donor_loss | 0.8500 |
| 19:5784376:CCTG:C | donor_gain | 0.8300 |
| 19:5783965:CAGGG:C | donor_gain | 0.8100 |
| 19:5784371:CGGTA:C | donor_loss | 0.8000 |
| 19:5784372:GGTAC:G | donor_loss | 0.8000 |
| 19:5784373:GTACC:G | donor_loss | 0.8000 |
| 19:5784374:TACCT:T | donor_loss | 0.8000 |
| 19:5784375:A:AC | donor_loss | 0.8000 |
| 19:5784376:C:A | donor_loss | 0.8000 |
| 19:5784377:C:A | donor_loss | 0.8000 |
| 19:5784517:C:T | donor_gain | 0.7900 |
| 19:5784054:C:CC | acceptor_gain | 0.7800 |
| 19:5784378:T:A | donor_loss | 0.7600 |
| 19:5784578:A:AC | donor_gain | 0.7600 |
AlphaMissense
2691 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:5783997:A:G | W84R | 0.995 |
| 19:5783997:A:T | W84R | 0.995 |
| 19:5783995:C:A | W84C | 0.993 |
| 19:5783995:C:G | W84C | 0.993 |
| 19:5784020:T:C | D76G | 0.992 |
| 19:5784022:G:C | F75L | 0.992 |
| 19:5784022:G:T | F75L | 0.992 |
| 19:5784024:A:G | F75L | 0.992 |
| 19:5784030:A:G | C73R | 0.990 |
| 19:5784023:A:G | F75S | 0.988 |
| 19:5784002:A:T | I82N | 0.987 |
| 19:5784023:A:C | F75C | 0.986 |
| 19:5784009:A:C | Y80D | 0.983 |
| 19:5784002:A:C | I82S | 0.982 |
| 19:5784028:G:C | C73W | 0.981 |
| 19:5784050:A:G | F66S | 0.981 |
| 19:5783382:C:G | A289P | 0.980 |
| 19:5784014:C:G | R78P | 0.978 |
| 19:5783243:A:G | L335P | 0.977 |
| 19:5783368:G:C | F293L | 0.977 |
| 19:5783368:G:T | F293L | 0.977 |
| 19:5783370:A:G | F293L | 0.977 |
| 19:5784036:A:G | C71R | 0.977 |
| 19:5783996:C:G | W84S | 0.976 |
| 19:5784020:T:A | D76V | 0.976 |
| 19:5784029:C:T | C73Y | 0.976 |
| 19:5784035:C:T | C71Y | 0.973 |
| 19:5783213:A:C | I345S | 0.972 |
| 19:5784032:C:A | G72V | 0.972 |
| 19:5783213:A:G | I345T | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000014187 (19:5783656 G>A,T), RS1001565377 (19:5786289 C>G), RS1001804489 (19:5785683 G>A), RS1003477091 (19:5784919 C>A), RS1003526643 (19:5784774 G>A,C), RS1004542091 (19:5786585 T>C,G), RS1006360455 (19:5785861 T>A,G), RS1006886821 (19:5786039 T>C), RS1008353061 (19:5786204 C>T), RS1008374410 (19:5784302 C>G,T), RS1009055110 (19:5785292 G>A), RS1009250895 (19:5783229 A>G), RS1010212344 (19:5786117 A>T), RS1010474839 (19:5786030 C>A,G), RS1010500281 (19:5782684 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| dicrotophos | increases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| abrine | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Diazinon | decreases methylation | 1 |
| Rotenone | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.